A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*

643 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007, methodology): “These risk-assessment strategies have been derived either from primary studies to determine risk factors or from clinical trials of prophylaxis (181), and they encompass selection (risk) criteria as simple as a Candida colonization index alone (232) or an ICU stay of 3 days (196) to more-complicated”
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. (2016, background): “particularly those with recurrent gastrointestinal perforation, anastomotic leaks, or acute necrotizing pancreatitis may be at uniquely high risk for candidiasis [238, 240, 243, 244].”
Epidemiology of Invasive Mycoses in North America (2010, background): “…substantial proportion of patients who actually go on to develop invasive candidiasis, and (3) be practical for use as selection tools for risk-targeted prevention (prophylaxis) or treatment (preemptive or empirical) strategies (Leon et al. 2006; Ostrosky-Zeichner et al. 2007; Wenzel et al. 2005).”